检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Serious adverse events (SAE) and suspected unexpected serious adverse reactions (SUSAR) in early stage patients with CLL treated with ibrutinib or placebo: safety results of the ongoing randomized CLL12 phase III-trial

Petra Langerbeins,Jasmin Bahlo, Christina Rhein,Paula Cramer,Anna-Maria Fink,Natali Pflug,Julia von Tresckow,Stephan Stilgenbauer,Karl-Anton Kreuzer,Michael J. Eckart,Ursula Vehling-Kaiser,Rudolf Schlag,Christina Balser, Lothar Mueller,Marcel Reiser,Clemens Wendtner,Kirsten Fischer,Barbara Eichhorst,Michael Hallek

LEUKEMIA & LYMPHOMA（2017）

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要